“Evidence from animal studies supports the idea that antibodies targeting the SARS-CoV-2 spike protein—the same protein that many vaccines use to trigger a protective immune response—might cause collateral damage."
“Evidence from animal studies supports the idea that antibodies targeting the SARS-CoV-2 spike protein—the same protein that many vaccines use to trigger a protective immune response—might cause collateral damage."